Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of Single-Nucleotide Polymorphisms of CTLA-4, CD80 and CD86 on the Effectiveness of Abatacept in Patients with Rheumatoid Arthritis.
Marquez Pete N, Maldonado Montoro MDM, Pérez Ramírez C, Sánchez Martín A, Martínez de la Plata JE, Martínez Martínez F, Caliz Caliz R, Daddaoua A, Ramírez Tortosa MDC, Jiménez Morales A. Marquez Pete N, et al. Among authors: caliz caliz r. J Pers Med. 2020 Nov 11;10(4):220. doi: 10.3390/jpm10040220. J Pers Med. 2020. PMID: 33187286 Free PMC article.
Genetic Polymorphisms of GGH and ABCC2 Are Associated with Methotrexate Intolerance in Patients with Rheumatoid Arthritis.
Escudero-Contreras A, López-Medina C, Collantes-Estévez E, Ortega-Castro R, Calvo-Gutiérrez J, Mena-Vázquez N, Panero-Lamothe B, Manzanares-Martín B, Cáliz-Cáliz R, Jiménez-Morales A, Ruiz-Jiménez M, Font-Ugalde P. Escudero-Contreras A, et al. Among authors: caliz caliz r. J Clin Med. 2021 Sep 9;10(18):4070. doi: 10.3390/jcm10184070. J Clin Med. 2021. PMID: 34575187 Free PMC article.
Comparative effectiveness of treatment with the first TNF antagonist in monotherapy, the first TNF antagonist plus one conventional synthetic disease-modifying antirheumatic drug, and the first TNF antagonist plus two or more conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
Hernández-Cruz B, Márquez-Saavedra E, Caliz-Caliz R, Navarro-Sarabia F. Hernández-Cruz B, et al. Among authors: caliz caliz r. Arthritis Res Ther. 2016 Nov 8;18(1):259. doi: 10.1186/s13075-016-1137-4. Arthritis Res Ther. 2016. PMID: 27821150 Free PMC article.
Two-year efficacy of tocilizumab in patients with active rheumatoid arthritis in clinical practice.
Notario Ferreira I, Ferrer González MA, Morales Garrido P, González Utrilla A, García Sanchez A, Soto Pino MJ, Suero Rosario E, Caro Hernández C, Añón Oñate I, Pérez Albaladejo L, Cáliz Cáliz R. Notario Ferreira I, et al. Among authors: caliz caliz r. Reumatol Clin. 2017 Mar-Apr;13(2):78-84. doi: 10.1016/j.reuma.2016.03.014. Epub 2016 May 10. Reumatol Clin. 2017. PMID: 27174398 Free article. English, Spanish.
Tocilizumab in COVID-19: Factors Associated With Mortality Before and After Treatment.
Sarabia De Ardanaz L, Andreu-Ubero JM, Navidad-Fuentes M, Ferrer-González MÁ, Ruíz Del Valle V, Salcedo-Bellido I, Barrios-Rodríguez R, Cáliz-Cáliz R, Requena P. Sarabia De Ardanaz L, et al. Among authors: caliz caliz r. Front Pharmacol. 2021 Jul 1;12:620187. doi: 10.3389/fphar.2021.620187. eCollection 2021. Front Pharmacol. 2021. PMID: 34276355 Free PMC article.
Real-World Effectiveness and Treatment Retention of Secukinumab in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: A Descriptive Observational Analysis of the Spanish BIOBADASER Registry.
Moreno-Ramos MJ, Sanchez-Piedra C, Martínez-González O, Rodríguez-Lozano C, Pérez-Garcia C, Freire M, Campos C, Cáliz-Caliz R, Calvo J, Blanco-Madrigal JM, Pérez-Gómez A, Moreno-Martínez MJ, Linares L, Sánchez-Alonso F, Sastré C, Castrejón I. Moreno-Ramos MJ, et al. Among authors: caliz caliz r. Rheumatol Ther. 2022 Aug;9(4):1031-1047. doi: 10.1007/s40744-022-00446-9. Epub 2022 Apr 25. Rheumatol Ther. 2022. PMID: 35467242 Free PMC article.
Safety and effectiveness of bDMARDs during pregnancy in patients with rheumatic diseases: Real-world data from the BIOBADASER registry.
Membrive-Jiménez C, Sánchez-Piedra C, Martínez-González O, García-González J, Expósito-Pérez L, Bohórquez-Heras C, Campos-Fernández C, Sanchez-Alonso F, Cáliz-Cáliz R, Castrejón-Fernández I. Membrive-Jiménez C, et al. Among authors: caliz caliz r. Reumatol Clin (Engl Ed). 2023 Nov;19(9):500-506. doi: 10.1016/j.reumae.2023.02.005. Reumatol Clin (Engl Ed). 2023. PMID: 37945183 Free article.
25 results